effects of tirzepatide TrimRX Tirzepatide Side Effects Cancer: Evidence

Semaglutide and tirzepatide use standard bacteriostatic water

At a median follow-up of 3.4 years, adults assigned semaglutide had lower risk for major kidney disease events compared with those assigned placebo (Graphic)

In sum, current evidence positions GLP-1 RAs as a potential cardioprotective strategy in HF, with HF with preserved ejection fraction emerging as the clinically most relevant phenotype for the drug class, especially when occurring in people with obesity with and without diabetes

This finding aligns with research showing that metabolic flexibility decreases with age, potentially limiting responsiveness to hormone-based interventions